Cannabis Stock Gainers And Losers From January 31, 2024
Portfolio Pulse from Benzinga Insights
The article lists the cannabis stocks that experienced significant gains and losses on January 31, 2024. Notable gainers include Rhinomed, GrowLife, and Elixinol Wellness with increases of 200%, 100%, and 69.3% respectively. On the losing side, MedMen Enterprises and EVIO both plummeted by 99%. The article also mentions several other cannabis-related companies with varying degrees of price changes.
January 31, 2024 | 9:30 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Aurora Cannabis shares decreased by 3.03%, closing at $0.38.
The fall in Aurora Cannabis' stock price may suggest short-term negative momentum, but the impact is likely moderate without additional news.
CONFIDENCE 80
IMPORTANCE 40
RELEVANCE 50
NEGATIVE IMPACT
Tilray Brands experienced a 3.68% decrease in stock price, ending at $1.83.
Tilray Brands' stock price drop could indicate short-term bearish sentiment, potentially leading to further declines.
CONFIDENCE 80
IMPORTANCE 40
RELEVANCE 50
NEGATIVE IMPACT
22nd Century Group shares fell by 7.96%, closing at $0.18.
The decline in 22nd Century Group's stock price suggests negative investor sentiment, potentially leading to short-term downward pressure.
CONFIDENCE 80
IMPORTANCE 40
RELEVANCE 50
POSITIVE IMPACT
Corbus Pharmaceuticals shares increased by 6.12% closing at $26.70.
The increase in share price indicates positive investor sentiment which could lead to short-term momentum, but without specific news, the impact may be moderate.
CONFIDENCE 80
IMPORTANCE 40
RELEVANCE 50
POSITIVE IMPACT
Greenlane Holdings' stock price increased by 4.92%, closing at $0.51.
The rise in Greenlane Holdings' shares could suggest short-term positive momentum, but the impact is likely moderate without specific catalysts.
CONFIDENCE 80
IMPORTANCE 40
RELEVANCE 50
POSITIVE IMPACT
Neptune Wellness Solutions ended the day up by 4.66% at $0.49 per share.
Neptune Wellness Solutions' stock increase may lead to short-term positive momentum, but the overall impact is likely moderate.
CONFIDENCE 80
IMPORTANCE 40
RELEVANCE 50
POSITIVE IMPACT
Psychemedics shares saw an uptick of 5.74%, ending the day at $3.50.
The gain in Psychemedics' stock price suggests a positive short-term outlook, though the impact is likely to be moderate without further context.
CONFIDENCE 80
IMPORTANCE 40
RELEVANCE 50